Cart
sales@molnova.com
Gp100 (25-33), human TFA
CAS No. ——
Gp100 (25-33), human TFA( —— )
Catalog No. M30115 CAS No. ——
Gp100 (25-33), human TFA is a 25-33 amino acid fragment of human melanoma antigen.Gp100 (25-33), human TFA is a 9-amino acid (AA) epitopes restricted by h-2db and recognized by T cells.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
Biological Information
-
Product NameGp100 (25-33), human TFA
-
NoteResearch use only, not for human use.
-
Brief DescriptionGp100 (25-33), human TFA is a 25-33 amino acid fragment of human melanoma antigen.Gp100 (25-33), human TFA is a 9-amino acid (AA) epitopes restricted by h-2db and recognized by T cells.
-
DescriptionGp100 (25-33), human TFA is a 25-33 amino acid fragment of human melanoma antigen.Gp100 (25-33), human TFA is a 9-amino acid (AA) epitopes restricted by h-2db and recognized by T cells.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number——
-
Formula Weight1269.33
-
Molecular FormulaC54H83F3N16O16
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical NameSequence:Lys-Val-Pro-Arg-Asn-Gln-Asp-Trp-Leu
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
Overwijk WW, et al. gp100/pmel 17 is a murine tumor rejection antigen: induction of "self"-reactive, tumoricidal T cellsusing high-affinity, altered peptide ligand. J Exp Med. 1998 Jul 20;188(2):277-86.
molnova catalog
related products
-
1-Furfurylpyrrole
1-Furfurylpyrrole is a potential contributor of flavor and aroma to popcorn.
-
Imazamox
Imazamox is a systemic herbicide with high selectivity, high activity, safety and broadspectrum activity.
-
Thrombin inhibitor 5
Thrombin inhibitor 5 (compound 385) is a thrombin inhibitor with IC50 values ranging from 0.1 μM to 1 μM, suitable for venous thromboembolism research.
